Home
Product Catalog
APIs (GMP Plants)
APIs (GMP Plants) for injection
APIs Intermediates
APIs Water Soluble Powder
Premix & Additive
Disinfectant
Agrochemicals
Medical Anatomical models
News
About us
Contact Us

Product Catalog 

 

Erlotinib (Cas:183321-74-6)

Model No.︰API-Erlotinib
Brand Name︰Huavet
Country of Origin︰China
Minimum Order︰1 gram
Share on:

 Total 55 Related Items 
Prev1718192021Next

Product Description

Product Name: Erlotinib

CAS No.: 183321-74-6

Information: EGFR tyrosine kinase inhibitor

Other Names: NSC 718781;OSI-744;R-1415;OSI744;OSI 744;R1415;R 1415; Tarceva

Chemical Name: N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine

Canonical SMILES: COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC

MF: C22H23N3O4

MW: 393.44

Purity: 99%

Type: Anticancer drugs

Grade Standard: Medicine Grade

Brand Name: Huavet

Place of Origin: Shaanxi, China (Mainland)

Solubility: Soluble in DMSO 

Storage: Store at -20°C 

General tips: For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 for several months. 

Shipping Condition: Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request

Background: Erlotinib (also known as NSC 718781 or CP 358,774) is a potent and orally-bioavailable inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase that selectively and reversibly inhibits EGFR-associated intracellular autophosphorylation of tyrosine kinase. Erlotinib inhibits purified EGFR tyrosine kinase and EGFR autophosphorylation intact cells with 50% inhibition concentration IC50 values of 2 nmol/L and 20 nmol/L respectively. Erlotinib competes for the ATP-binding sits on the intracellular domain of EGFR resulting in the inhibition of downstream signaling pathway involved in angiogenesis, cell propagation and cell survival. Erlotinib concentration-dependently inhibits EGFR-mediated propagation signals transduction, displays prominent anti-tumor activity against neoplasms harboring EGFR expression and exhibits a tolerable toxicologic profile.

Usage: Pharmaceutical Intermediates

Inventory status: in stock

Shelf life: 2 years

Sample: Available

COA (Certificate Of Analysis): Available

MSDS (Material Safety Data Sheet): Available

HPLC Spectrum: Available

ISO: Approved

GC: Available

NMR (Nuclear Magnetic Resonance): Available

Packaging Details:1g,5g,10g,50g,100g/bottle, 1kg/tin for trial order,25kg/drum for commercial quantity. Specific packing required by customer

Delivery Detail: Prompt shipment

 

Related Products

•Dacomitinib (PF299804, PF299)

AG-490 (Tyrphostin B42)

AG-18

AZD8931 (Sapitinib)

Varlitinib (ARRY334543)

Neratinib (HKI-272)

Product Image


Related Products
Afatinib (Cas: 439081-18-2 )
Afatinib (Cas: 439081-18-2 )
Apixaban (Cas:503612-47-3 )
Apixaban (Cas:503612-47-3 )
Alogliptin (Cas: 850649-61-5)
Alogliptin (Cas: 850649-61-5)
Alogliptin Benzoate (Cas:850649-62-6)
Alogliptin Benzoate (Cas:850649-62-6)

Home  |  Product Catalog  |  APIs (GMP Plants)  |  APIs (GMP Plants) for injection  |  APIs Intermediates  |  APIs Water Soluble Powder  |  Premix & Additive  |  Disinfectant  |  Agrochemicals  |  Medical Anatomical models  |  News  |  About us  |  Contact Us  |  Sitemap  |  Mobile Version
经营许可证编号:陕ICP备08105542号
Powered by DIYTrade.com